According to Deep Tide TechFlow, on August 7, Processa Pharmaceuticals announced that it has secured strategic investment and plans to incorporate cryptocurrency into its corporate financial management strategy. The company has appointed LifeSci Capital as its advisor.
Processa stated that this move aims to diversify the capital structure and enhance financial flexibility. The company will explore using blockchain assets to support its clinical development projects, while strictly adhering to regulatory standards.